Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Purpose

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Condition

  • Endometrial Carcinoma

Eligibility

Eligible Ages
Over 45 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-identified Black individuals ≥ 45 years with an intact uterus - Assigned female sex at birth - Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause) - Willing to participate in a 45-minute virtual interview

Exclusion Criteria

  • Previous or current diagnosis of endometrial cancer

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
Observational Participants complete a semi-structured interview on study.
  • Other: Non-Interventional Study
    Non-interventional study
    Other names:
    • Non-Interventional Observational Study
    • Noninterventional (Observational) Study

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905
Contact:
Clinical Trials Referral Office
855-776-0015

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Clinical Trials Referral Office
855-776-0015
mayocliniccancerstudies@mayo.edu